Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Koenig

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Arthritis and Rheumatism|November 30, 2006
The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritisTimothy R D J Radstake, Barbara Franke, Mark H Wenink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell MalignanciesLiqin Liu, Chia-Ying K Lam, Vatana Long, et al.
Blood|February 9, 2011
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphomaPaul A Moore, Wenjun Zhang, G Jonah Rainey, et al.
Developmental Cell|June 20, 2018
Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and RepairChuntao Zhao, Chen Dong, Magali Frah, et al.
Lancet (London, England)|July 2, 2011
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trialNicole Sherry, William Hagopian, Johnny Ludvigsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2023
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesisKimberly A Dowd, Devika Sirohi, Scott D Speer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent diseaseMark H Wenink, Kim C M Santegoets, Mieke F Roelofs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2012
Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activityDeryk Loo, Ralph F Alderson, Francine Z Chen, et al.
Molecular Cancer Therapeutics|September 24, 2020
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid CancerJuniper A Scribner, Jennifer G Brown, Thomas Son, et al.
Molecular Cancer Therapeutics|June 6, 2018
Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal CancerPaul A Moore, Kalpana Shah, Yinhua Yang, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|November 30, 2006
The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritisTimothy R D J Radstake, Barbara Franke, Mark H Wenink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell MalignanciesLiqin Liu, Chia-Ying K Lam, Vatana Long, et al.
Blood|February 9, 2011
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphomaPaul A Moore, Wenjun Zhang, G Jonah Rainey, et al.
Developmental Cell|June 20, 2018
Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and RepairChuntao Zhao, Chen Dong, Magali Frah, et al.
Lancet (London, England)|July 2, 2011
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trialNicole Sherry, William Hagopian, Johnny Ludvigsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2023
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesisKimberly A Dowd, Devika Sirohi, Scott D Speer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent diseaseMark H Wenink, Kim C M Santegoets, Mieke F Roelofs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2012
Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activityDeryk Loo, Ralph F Alderson, Francine Z Chen, et al.
Molecular Cancer Therapeutics|September 24, 2020
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid CancerJuniper A Scribner, Jennifer G Brown, Thomas Son, et al.
Molecular Cancer Therapeutics|June 6, 2018
Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal CancerPaul A Moore, Kalpana Shah, Yinhua Yang, et al.
Pageof 6